Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Consumer Discretionary · ·
$37.43
▲ $0.26 (+0.7%)
Market data updated: 09/15 10:55 PM
Fundamentals updated: 09/15/2026
News analyzed: 09/15/2026
Market Cap
$781.10M
Day Range
$36.56 - $37.48
52-Week Range
$30.75 - $50.88
Beta
—
Next Earnings
22.09.2026
APOG is a stock from the Consumer Cyclical sector — Retail, automotive, and leisure — demand rises and falls with economic sentiment and consumers' disposable income.
-12.3% (1Y)
Strengths: 9/32 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
DCF Fair Value
Estimated fair value: $55.64 vs. price $37.43 (+48.6%)
Fair Value
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: -0.14 (3y annualized return -8.8% / max drawdown 63.6%)
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 1 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 1
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
50
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
42
Quality
63
Value
67
Momentum
13
Risk
54
Sentiment
100
Fundamental
59
Institutional
No data available
Stocks with a similar DNA right now
Not enough comparably-scored stocks yet to show similar matches.
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Apogee Enterprises, Inc. has primarily focused on its strategic expansion and leadership changes. In September 2026, the company announced plans to acquire **GroGlass** for up to **$72.5 million**, aiming to bolster its architectural building products and coated materials portfolio. Additionally, AbbVie’s pending acquisition of Apogee was noted to initially suppress its earnings per share before becoming accretive post-2032. Earlier in August, Apogee added two new independent directors—Joseph B. Hayek and Suresh Krishna—to its board. No other significant financial or operational updates were highlighted in the provided sources.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Apogee Enterprises, Inc.. News trend score: 100. Reason: 17 of the last 20 articles are positive, versus 1 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
19
🎯 Conviction (vs. Emotion)
42
Psychology
54
Fundamentals
59
Technical
13
Valuation
67
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Price (3M)
-6%
Market Narrative
43
Fundamental Reality
42
Narrative Gap
+1
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
APOG’s psychology is fragmented, with **FOMO** and **Euphoria** competing against **Panic Selling**—all fueled by extreme positive sentiment (100/100) and elevated volume (1.39x avg). The narrative-reality gap (5 points) suggests traders may be overestimating fundamentals, given the stock’s 28% discount to DCF fair value and diverging momentum vs. EPS growth. The key question: *Is the euphoria masking a disconnect between price action and intrinsic value?* The absence of anchoring or loss aversion implies no defensive positioning, while the lack of herding or confirmation bias suggests no clear consensus narrative.
Updated: 09/08/2026, 12:17 AM
👥 What the crowd believes
"Apogee Enterprises to acquire SIA 'GroGlass' for up to €62.5 million"
"Joseph B. Hayek and Suresh Krishna join Apogee’s Board of Directors"
"Christopher W. Ede, President at Apogee, made a notable insider purchase"
📈 3D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 93/100
🔴 Weakest match
Jesse Livermore — 28/100
🗣️ Why do they disagree?
This stock splits the historical methodologies into two starkly different camps: the more bullish, value-oriented approaches see potential, while the growth-focused or market-critical frameworks dismiss it outright. Charles Mackay’s crowd psychology model and Edgar Lawrence Smith’s long-term buy-and-hold criteria both rate it favorably, suggesting it lacks speculative frenzy and could benefit from patient holding. Meanwhile, Benjamin Graham’s stricter valuation tests and Philip Fisher’s quality/growth standards reject it, while Thorstein Veblen and Peter Lynch flag it as a speculative or overpriced growth play. The middle ground—seen in Howard Marks’ mixed assessment or Samuel Nelson’s cyclical favorability—reflects uncertainty over whether the stock’s fundamentals justify its valuation, leaving it in a gray area between cautious optimism and outright skepticism.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 93
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 78
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟢 72
Attractive to a Defensive Graham Investor
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 68
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 67
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 54
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 53
Adequate but not exceptional liquidity
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 53
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟡 51
Moderate — holdable, but not effortless
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 49
Some discount, but not the deep 'net-net' bargain Graham's enterprising bar sets
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 49
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 48
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 36
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 34
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 30
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 28
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Based on the last 277 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (0 bullish · 10 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
A trading range after an advance, but still without clear (volume-based) confirmation of a distribution phase.
Low confidence
$36.56
Range Bottom
$44.05
Range Top
50
Trading Days in Range
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
22.7%
Operating Margin
6.0%
Net Margin
3.9%
EBITDA Margin
9.6%
ROE
10.6%
ROA
4.8%
ROIC
—
EPS
$2.54
Cash
$39.52M
Total Debt
$232.28M
Current Ratio
1.65
Debt/Equity
0.45
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 14.7.2026 | $0.270 |
| 13.7.2026 | $0.270 |
| 13.5.2026 | $0.270 |
| 12.5.2026 | $0.270 |
| 3.2.2026 | $0.270 |
| 2.2.2026 | $0.270 |
| 29.10.2025 | $0.260 |
| 28.10.2025 | $0.260 |
| 16.7.2025 | $0.260 |
| 15.7.2025 | $0.260 |
| 13.5.2025 | $0.260 |
| 12.5.2025 | $0.260 |
How is Fair Value calculated? →
Current Price
$37.43
Estimated Fair Value (DCF)
$55.64
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
+48.6%
🟢 Appears cheap relative to estimated value
Year 1 Growth Rate
-0.8%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | -0.8% | $94.40M | $86.61M |
| 2 | 0.0% | $94.43M | $79.48M |
| 3 | 0.9% | $95.23M | $73.54M |
| 4 | 1.7% | $96.83M | $68.60M |
| 5 | 2.5% | $99.25M | $64.51M |
Base FCF (last actual year)
$95.16M
Terminal Value
$1.57B
Present Value of Terminal Value
$1.02B
Enterprise Value
$1.39B
Net Debt
$192.76M
Equity Value
$1.20B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$23.79
Tangible Book Value per Share (Tangible NAV)
$7.61
Sentiment based on basic keywords (not AI) — 17 positive, 2 neutral, 1 negative out of the last 20 articles.
Yahoo · 14.9.2026
Yahoo · 14.9.2026
Yahoo · 9.9.2026
SeekingAlpha · 9.9.2026
Yahoo · 9.9.2026
Benzinga · 3.9.2026
MT Newswires · 2.9.2026
Yahoo · 2.9.2026
Business Wire · 2.9.2026
Benzinga · 2.9.2026
Business Wire · 5.8.2026
Yahoo · 5.8.2026
SeekingAlpha · 24.7.2026
Business Wire · 24.7.2026
Zacks · 22.7.2026
Zacks · 22.7.2026
Benzinga · 22.7.2026
SeekingAlpha · 18.7.2026
Zacks · 9.7.2026
Zacks · 7.7.2026
Apogee Enterprises, Inc. (APOG) currently has a StockIQ AI score of 50/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
APOG currently scores 50/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, APOG's estimated fair value is $55.64, which is 48.6% above the current price of $37.43. This is one valuation model among several signals in the fair-value category, not a price target.
APOG's technical score is 13/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Estimated fair value: $55.64 vs. price $37.43 (+48.6%); Operating margin is stable or improving over time; Debt/equity: 0.45.
Based on the real signals StockIQ computed: Calmar: -0.14 (3y annualized return -8.8% / max drawdown 63.6%); Earnings per share (EPS) growth: -35.2%; Net income growth: -36.4%.
Yes — APOG has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Wagner Patricia K | Gift | 7.8.2026 | 2,419 | -2,419 | — |
| Krishna Suresh | Grant/Award from Employer | 5.8.2026 | 2,454 | +2,454 | — |
| HAYEK JOSEPH B | Grant/Award from Employer | 5.8.2026 | 2,454 | +2,454 | — |
| HAYEK JOSEPH B | Grant/Award from Employer | 5.8.2026 | 2,454 | +2,454 | — |
| Krishna Suresh | Grant/Award from Employer | 5.8.2026 | 2,454 | +2,454 | — |
| Ede Christopher Willliam | Grant/Award from Employer | 6.7.2026 | 5,089 | +5,089 | $39.79 |
| Ede Christopher Willliam | Grant/Award from Employer | 6.7.2026 | 5,026 | +5,026 | $39.79 |
| Ede Christopher Willliam | Grant/Award from Employer | 6.7.2026 | 21,194 | +5,026 | $39.79 |
| Ede Christopher Willliam | Grant/Award from Employer | 6.7.2026 | 26,283 | +5,089 | $39.79 |
| Nolan Donald A | Grant/Award from Employer | 30.6.2026 | 430 | +430 | $45.74 |
| Alvord Christina M | Grant/Award from Employer | 30.6.2026 | 63 | +63 | $45.74 |
| POMPA MARK A | Grant/Award from Employer | 30.6.2026 | 60 | +60 | $45.74 |
| POMPA MARK A | Grant/Award from Employer | 30.6.2026 | 147 | +147 | $45.74 |
| Nolan Donald A | Grant/Award from Employer | 30.6.2026 | 62 | +62 | $45.74 |
| Lilly Elizabeth Murphy | Grant/Award from Employer | 30.6.2026 | 41 | +41 | $45.74 |
| POMPA MARK A | Grant/Award from Employer | 30.6.2026 | 10,135 | +60 | $45.74 |
| POMPA MARK A | Grant/Award from Employer | 30.6.2026 | 27,728 | +147 | $45.74 |
| Nolan Donald A | Grant/Award from Employer | 30.6.2026 | 10,675 | +62 | $45.74 |
| Nolan Donald A | Grant/Award from Employer | 30.6.2026 | 73,275 | +430 | $45.74 |
| Alvord Christina M | Grant/Award from Employer | 30.6.2026 | 13,343 | +63 | $45.74 |
| Lilly Elizabeth Murphy | Grant/Award from Employer | 30.6.2026 | 9,682 | +41 | $45.74 |
| Parker Herbert K | Grant/Award from Employer | 24.6.2026 | 2,741 | +2,741 | $41.96 |
| POMPA MARK A | Grant/Award from Employer | 24.6.2026 | 2,741 | +2,741 | $41.96 |
| Lilly Elizabeth Murphy | Grant/Award from Employer | 24.6.2026 | 2,741 | +2,741 | $41.96 |
| Wagner Patricia K | Grant/Award from Employer | 24.6.2026 | 2,741 | +2,741 | $41.96 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
840,316 shares short as of 2026-08-31 · vs. 653,122 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
77.9% of trading volume this week was short selling, vs. 56.0% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology